Rocco Sgobbo - Profile and Investment Details

Investor Profile

Rocco Sgobbo is a Venture Capital, Private Equity Firm, Investor based in Switzerland with a diverse investment portfolio that includes companies such as Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics, Peloton Therapeutics, Arvinas, Cullinan OncologySilverback Therapeutics, Sunesis Pharmaceuticals, MolecularMD, MOMA Therapeutics, Scorpion Therapeutics, PMV Pharmaceuticals, Cleave Therapeutics, Partners Group, Vividion Therapeutics, Turning Point Therapeutics, ImaginAb, Neon Therapeutics, Telormedix, Ganymed Pharmaceuticals, Circle Pharma, EQRx, Kronos Bio, A2 Biotherapeutics, TetraLogic Pharmaceuticals, Kinnate Biopharma, Arrakis Therapeutics, Revolution Medicines, Kura Oncology, IconOVir Bio, IDEAYA Biosciences, Autolus, C4 Therapeutics, Agensys, Falcon Private Bank Ltd., . Over time, Rocco Sgobbo has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rocco Sgobbo is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Drug Discovery, Wellness, Women Founded, Immunotherapy, Life Science, Portfolio Management, Information Technology (IT), Finance, Biotechnology, Precision Medicine, Travel, Medical, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Rocco Sgobbo, as their portfolio suggests a familiarity and interest in this area.

Understanding Rocco Sgobbo’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.